{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:53:59Z","timestamp":1763016839421},"reference-count":59,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T00:00:00Z","timestamp":1202688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Invasive aspergillosis (IA) is an important infectious complication in allogeneic stem cell transplant (SCT) recipients. Diagnosis of IA has been difficult and often delayed and treatment outcome has been poor, with mortality rates up to 80%. This review summarizes recent developments in this field. There are indications that the incidence of IA may be decreasing due to multiple factors including better understanding of pathogenesis of IA, earlier diagnosis, and various prophylactic and preventive strategies. Recently posaconazole has shown to be effective in reducing the risk of IA in patients treated for graft\u2010versus\u2010host disease (GVHD). Early use of high\u2010resolution thoracic computed tomography assisted with complimentary methods including bronchoalveolar lavage and serum galactomannan determinations are useful in early diagnosis. Our treatment armamentarium against IA has broadened significantly during the last years and there are some indications of improved outcome more recently. On the other hand, increasing use of blood progenitor grafts instead of marrow with higher risk of chronic GVHD, increasing age of SCT recipients, and wide use of donor lymphocyte infusions for treatment of minimal residual disease or relapse may affect to the opposite direction. Despite some promises and improvements, IA will continue to remain a challenge in the upcoming years.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00301.x","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T09:20:18Z","timestamp":1202721618000},"page":"156-161","source":"Crossref","is-referenced-by-count":20,"title":["Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients"],"prefix":"10.1111","volume":"10","author":[{"given":"E.","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nihtinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.\u2010J.","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,11]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"575","article-title":"Changes in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe","volume":"36","author":"Gratwohl A","year":"2005","journal-title":"a report of the EBMT activity survey 2003"},{"key":"e_1_2_8_3_2","first-page":"71","article-title":"Results of the EBMT activity survey 2005 on hematopoietic stem cell transplantation","volume":"39","author":"Gratwohl A","year":"2007","journal-title":"focus on increasing use of unrelated donors"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700737"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/516480"},{"key":"e_1_2_8_6_2","first-page":"4358","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients","volume":"100","author":"Marr KA","year":"2002","journal-title":"changes in epidemiology and risk factors"},{"key":"e_1_2_8_7_2","first-page":"288","article-title":"Epidemiology of invasive aspergillosis in France","volume":"51","author":"Cornet M","year":"2002","journal-title":"a six-year multicentric survey in the Greater Paris area"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704543"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705181"},{"key":"e_1_2_8_10_2","first-page":"475","article-title":"Invasive fungal infections after allogeneic peripheral blood stem cell transplantation","volume":"116","author":"Martino R","year":"2002","journal-title":"incidence and risk factors in 395 patients"},{"key":"e_1_2_8_11_2","first-page":"891","article-title":"Candidaemia in allogeneic stem cell transplant recipients","volume":"34","author":"Jantunen E","year":"2004","journal-title":"low risk without fluconazole prophylaxis"},{"issue":"1","key":"e_1_2_8_12_2","first-page":"S176","article-title":"Relapse of acute leukaemia or myelodysplastic syndrome after an allogeneic stem cell transplantation","volume":"39","author":"Nihtinen A","year":"2007","journal-title":"increased risk of invasive mould infections"},{"issue":"1","key":"e_1_2_8_13_2","first-page":"S49","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation","volume":"43","author":"Morgan J","year":"2005","journal-title":"interim results of a prospective multicenter surveillance program"},{"key":"e_1_2_8_14_2","first-page":"7","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants","volume":"34","author":"Ascioglu S","year":"2002","journal-title":"an international consensus"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2007.00272.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22909"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0456"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2004.06.003"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.02.012"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/319985"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0456"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703812"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2005.01.001"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.253"},{"key":"e_1_2_8_25_2","first-page":"373","article-title":"Imaging findings in acute invasive aspergillosis","volume":"44","author":"Greene RE","year":"2007","journal-title":"clinical significance of the halo sign"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.03.005"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3922-3925.2003"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5517-5522.2004"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00373.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/343804"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05140.x"},{"key":"e_1_2_8_32_2","first-page":"1242","article-title":"Galactomannan and computed tomography\u2010based pre\u2010emptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection","volume":"41","author":"Maertens J","year":"2005","journal-title":"a prospective feasibility study"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/444462"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.02.072"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.2.389-394.2006"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/429921"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05887.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/499949"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01344-06"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/512812"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/432470"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.12.5957-5962.2005"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0733"},{"key":"e_1_2_8_45_2","first-page":"192","article-title":"Infections due to Aspergillus terreus","volume":"39","author":"Steinbach WJ","year":"2004","journal-title":"a multicenter retrospective analysis of 83 cases"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcsup.2007.06.007"},{"key":"e_1_2_8_47_2","first-page":"2","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy","volume":"44","author":"Walsh TJ","year":"2007","journal-title":"an externally controlled trial"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1086\/423381"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22348"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705559"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.03.003"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1086\/423380"},{"key":"e_1_2_8_53_2","first-page":"939","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients","volume":"34","author":"Boutboul F","year":"2002","journal-title":"increasing antigenemia is associated with progressive disease"},{"key":"e_1_2_8_54_2","first-page":"955","article-title":"Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation","volume":"42","author":"Cordonnier C","year":"2006","journal-title":"a 1-year retrospective study of consecutive patients at French transplantation centres"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705749"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-9-200305060-00006"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2644"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061098"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcsup.2007.06.006"},{"key":"e_1_2_8_60_2","first-page":"4288","article-title":"Long\u2010term outcome of patients given transplants of mobilized blood or bone marrow","volume":"108","author":"Schmitz N","year":"2006","journal-title":"a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:21:50Z","timestamp":1697296910000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00301.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,11]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00301.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00301.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,11]]}}}